Matthew Surman

USPTO Granted Patents = 20 (Patent Applications = 7)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 76(Granted Patents)

Company Filing History:

14 out of 97

Albany Molecular Research, Inc.

patents

2 out of 33

Affinium Pharmaceuticals, Inc.

patents

2 out of 2,925

University of Florida Research Foundation, Incorporated

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473296 - Perk inhibiting compounds (2025-11-18),

2. 12338240 - Nonmuscle myosin ii inhibitors (2025-06-24),

3. 12331054 - Perk inhibiting imidazolopyrazine compounds (2025-06-17),

4. 11649234 - Nonmuscle myosin II inhibitors for substance use relapse (2023-05-16),

5. 11020386 - Methods and compositions for preventing opioid abuse (2021-06-01),

6. 10695342 - Methods and compositions for preventing opioid abuse (2020-06-30),

7. 9650378 - (1-azinone)-substituted pyridoindoles (2017-05-16),

8. 9296743 - (1-azinone)-substituted pyridoindoles (2016-03-29),

9. 9073925 - Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof (2015-07-07),

10. 8993765 - Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof (2015-03-31),

11. 8716308 - (1-azinone)-substituted pyridoindoles (2014-05-06),

12. 8697700 - Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof (2014-04-15),

13. 8637501 - [object Object] (2014-01-28),

14. 8629158 - Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof (2014-01-14),

15. 8618299 - Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof (2013-12-31),

Title: Unveiling the Inventive Mind of Matthew Surman from Albany, NY

Introduction: Matthew Surman is a prolific inventor hailing from Albany, NY, who has left an indelible mark in the world of patents with his groundbreaking innovations.

Latest Patents: With an impressive portfolio of 17 patents, Matthew's latest inventions include "Nonmuscle Myosin II Inhibitors for Substance Use Relapse" and "Methods and Compositions for Preventing Opioid Abuse." The former introduces compounds effective in treating various medical conditions, while the latter focuses on abuse-resistant opioid compounds and drug delivery systems.

Career Highlights: Having worked at Albany Molecular Research, Inc. and Affinium Pharmaceuticals, Inc., Matthew Surman has showcased his expertise in the pharmaceutical industry by developing cutting-edge solutions for complex medical challenges. His patents stand as a testament to his dedication to advancing healthcare.

Collaborations: Throughout his journey, Matthew collaborated closely with esteemed professionals such as Peter Guzzo and Alan John Henderson. Together, they have contributed significantly to the field of pharmaceuticals and medical research, fostering a culture of innovation and excellence.

Conclusion: Matthew Surman's inventive spirit and commitment to improving patient care through innovative solutions have solidified his position as a prominent figure in the realm of patents and inventions. His contributions continue to inspire the next generation of inventors to push the boundaries of what is possible in the world of medicine and beyond.

This text is generated by artificial intelligence and may not be accurate.